Réaction #2146686

ord-4bc09b23fe4a40ff938a0b354a991ac2

Équation de réaction

O=C(CBr)c1ccc(O)cc1
2-bromo-4′-hydroxyacetophenone
COc1ccc(N)nc1
2-amino-5-methoxypyridine
COc1ccc2nc(-c3ccc(O)cc3)cn2c1
2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine
Rendement 81.6%

Solvants

Conditions de réaction

Température
90°CELSIUS
Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    AutreAfter the completion of the reaction
  2. 2
    Températurethe reaction solution was cooled down to room temperature
  3. 3
    Autreprecipitates
  4. 4
    Filtrationwere filtered
  5. 5
    Autrerecovered
  6. 6
    LavageThe precipitates were washed with acetonitrile
  7. 7
    Autredried under reduced pressure
  8. 8
    workup.ADDITIONThen, about 20 mL of a saturated sodium hydrogencarbonate solution was added
  9. 9
    Autrethe mixture was sonicated for 5 minutes
  10. 10
    AutrePrecipitates
  11. 11
    Filtrationwere filtered
  12. 12
    Autrerecovered from the resulting mixture
  13. 13
    Lavagesufficiently washed with water
  14. 14
    Autredried under reduced pressure

Mode opératoire

2.15 g (corresponding to 10.0 mmol) of 2-bromo-4′-hydroxyacetophenone and 1.25 g (corresponding to 10.0 mmol) of 2-amino-5-methoxypyridine were dissolved in 50 mL, of acetonitrile. The resulting solution was refluxed in an oil bath at 90° C. for 3.5 hours. After the completion of the reaction, the reaction solution was cooled down to room temperature, and precipitates were filtered and recovered. The precipitates were washed with acetonitrile and dried under reduced pressure. The resulting crude crystals were suspended in a mixed solution of 40 mL of water and 40 mL of methanol. Then, about 20 mL of a saturated sodium hydrogencarbonate solution was added thereto, and the mixture was sonicated for 5 minutes using a ultrasonic washing machine. Precipitates were filtered and recovered from the resulting mixture, sufficiently washed with water, and dried under reduced pressure, to obtain 1.96 g (corresponding to 8.16 mmol) of 2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine (FIG. 2, Step 5).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US08277777B2uspto-grants-2012_10